Hpv And Head And Neck Cancer An Issue Of Otolaryngologic Clinics E Book

HPV is a growing epidemic in head and neck cancer and specialists working with these diseases are provided information on shifting trends in HPV in head and neck cancers along with challenges and controversies in treating this disease. With this virus related cancer, there is a different approach to managing this patient population. Novel therapeutic treatments are actively being developed for this type of head and neck cancer. Topics include: Epidemioloygy of HPV-head and neck cancer; Clinical detection of HPV; Clinical evaluation and disease patterns of HPV-related head and neck cancers; Impact of HPV-related head and neck cancer in clinical trials; Molecular biology of HPV and head and neck cancer and targeted therapies; Transoral robotic surgery: new surgical techniques for oropharyngeal cancers; Economic impact of HPV-related cancers; Rehabilitation needs of oropharyngeal cancer patients; Psychosocial care needs of HPV-head and neck cancer patients; and a Multi-disciplinary approach to head and neck cancers.

While cancers of the oral cavity and oropharynx were overwhelming found in smokers and drinkers, a dramatic shift is occurring with a dramatic rise in the incidence of HPV-associated oropharyngeal cancers while oral cavity cancers and HPV-negative oropharyngeal cancers appear to be declining in incidence, reflecting the reduction in cigarette smoking. These trends also have implications for how Otolaryngologists prevent, diagnose, workup, treat, and follow these patients. The focus of information in this issue is on oral cavity and oropharyngeal cancer and the implications of the HPV epidemic on this disease. Amongst the medical community during this period of trying to better grasp the association of HPV with oropharyngeal cancers, there are misconceptions and a lack of knowledge of these important shifts which are addressed by Guest Editors Jeffrey Myers and Erich Sturgis of the University of Texas, MD Anderson Cancer Center. Topics include: Epidemiology- Control of a tobacco epidemic? But emergence of a HPV epidemic?; Oral cavity and Oropharyngeal Cancer Genomics; Why Otolaryngologists need to be aware of Fanconi anemia; Impact on HPV on Orpharyngeal Cancer Biology and Response to Therapy-Implications for Treatment; Oral premalignancy- The roles of early detection and chemoprevention; Evaluation and staging- Limitations despite technological breakthroughs; 7) Surgical treatment innovations; Radiotherapy- The “Particle-rs of energy, dose, and delivery method; Systemic Treatment- Its role before, during, and after definitive treatment; How to maximize functional assessment/rehabilitation; Standardizing treatment for Cancers – An approach to cancer care or crisis?; Survivorship in Oral Cancer- Competing mortalities, morbidities, and second malignancies.

This issue of Otolaryngologic Clinics, guest edited by Drs. Cecelia E. Schmalbach and Kelly M. Malloy, is dedicated to Head and Neck Cutaneous Cancer. This issue is one of six selected each year by the series Consulting Editor, Dr. Sujana S. Chandrasekhar. Cutaneous cancer rates are growing at epidemic proportions and consequently lead to a significant health care burden. This issue opens with an overview of the related biology, epidemiology, and preventative measures. A contemporary review of cutaneous cancer management will be provided to include the roles of sentinel node biopsy, surgery, radiation therapy, and systemic therapy. Cutaneous cancers impact the geriatric patient population, so ethical considerations and non-surgical management are emphasized.

This issue of Hematology/Oncology Clinics, guest edited by Dr. Glenn J. Hanna, will focus on Head and Neck Cancer. This issue is one of six selected each year by our series consulting editors, Dr. George P. Canellos and Dr. Edward J. Benz. This issue addresses the evaluation and management of the complex head and neck cancer patient with articles focused on unique epidemiology and therapeutic principles by subsite of disease. Additional information relevant to rare head and neck malignancies is included. The issue further focuses on the evolving applications of minimally invasive surgery in oropharynx cancer and the role of immunotherapy in the management of advanced disease. Topics include: Radiologic Evaluation of the Head and Neck Cancer Patient, Robotic and Endoscopic Approaches to Head and Neck Surgery, Cancer of the Oral Cavity and Lip, Cancer of the Oropharynx and the Association with Human Papillomavirus, Cancer of the Larynx and Hypopharynx, Cancer of the Nasal Cavity and Paranasal Sinuses, Cancer of the Nasopharynx and the Association with Epstein-Barr Virus, Salivary Glands Cancers, Thyroid and Parathyroid Cancers, Cutaneous Malignancies of the Head and Neck, Managing Recurrent and Metastatic Head and Neck Cancer, and Immunotherapy for Head and Neck Cancer. Provides in-depth, clinical reviews on head and neck cancer, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field; Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.

This book serves a snapshot of the current knowledge base in field. As human papillomavirus (HPV) causes a rising number of oropharyngeal cancers, understanding the biological, clinical and social implications of this infection has become increasingly important for head and neck practitioners. This book reflects the multidisciplinary nature of the scientific and clinical questions involved in this disease. Experts in epidemiology, diagnosis and treatment of HPV-related oropharyngeal cancer present in-depth reviews which will help to improve the reader’s understanding of this topic. The authors provide insight for answers of common patient and provider questions about HPV infection and related disease, and highlight remaining questions to be answered in the coming years.

In this issue of Otolaryngologic Clinics, guest editors Drs. Karen M. Kost and Gina D. Jefferson bring their considerable expertise to the topic of Larynx Cancer. Top experts in the field cover key topics such as perioperative assessment/prehabilitation; dysplastic lesions of the larynx; radiation for early glottic cancer; surgical management of supraglottic cancer; salvage surgery; vocal rehabilitation and quality of life; swallowing function after treatment of laryngeal cancer; end-of-life care; and more. Contains 18 relevant, practice-oriented topics including diagnostic assessment (imaging) and staging of laryngeal cancer; surgical treatment of early glottic cancer; surgical management of advanced glottic cancer; the role of robotic surgery in laryngeal cancer; reconstruction options; and more. Provides in-depth clinical reviews on larynx cancer, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

This issue of Surgical Oncology Clinics of North America, edited by Dr. John Ridge, is devoted to Head and Neck Cancer.Articles in this issue include: Epidemiology of Head and Neck Cancer; Molecular Biology and Immunology; Examination of the patient with Head and Neck Cancer; Imaging of Head and Neck Cancer; Principles of Radiation Treatment; Principles of Chemotherapy; Principles and Practice of Reconstructive Surgery; Oral Cavity; Oropharynx; Unknown primary; Larynx and Hypopharynx; Nasopharynx; Nose and Sinus; Head and Neck Skin Cancer; and Tumors of the major Salivary Glands.